Introduction
Microtubule-targeted drugs, such as the Vinca alkaloids and taxanes, are widely used clinically, and their antimitotic effects on tumor cells are believed to result from the suppression of spindle microtubule dynamic instability. However, these drugs also inhibit microtubule function in non-dividing cells, which can result in serious side effects, as is seen in peripheral neuropathy, in which axonal transport is disturbed in peripheral neurons. To overcome this problem, new therapeutic agents that target spindle-regulatory proteins are being developed to inhibit the mitotic spindle without affecting microtubule function in non-dividing cells (Sudakin and Yen, 2007) . Among these, the motor protein kinesin-5 (Eg5, Ksp), Aurora kinases and Polo-like kinases have been studied extensively as potential drug targets. The antitumor activities of the inhibitors of these proteins have been shown using cancer cell lines and xenograft models (Keen and Taylor, 2004; Strebhardt and Ullrich, 2006; Jackson et al., 2007) . While these inhibitors showed improved side-effect profiles, their efficacies have not been shown to be comparable to Vinca alkaloids and taxanes in clinical studies (Harrison et al., 2009) . One possible explanation for this in vivo inefficiency is the complexity of human cancers. Unlike cultured cells, primary tumor cells are heterogeneous and grow as part of a microenvironment that influences cell proliferation, apoptosis and differentiation. Hence, validation of new potential chemotherapeutic targets in autochthonous tumors is critical.
The transforming acidic coiled-coil (TACC) protein family, which shares a highly conserved coiled-coil motif called the TACC domain, is evolutionarily conserved (Peset and Vernos, 2008) . Several lines of evidence have implicated these proteins in spindle assembly and centrosome function. One family member, Alp7/Mia1, has an essential role in bipolar spindle formation in fission yeast, and its disruption leads to spindle orientation defects (Oliferenko and Balasubramanian, 2002; Sato et al., 2004) . A Drosophila homolog, D-TACC, is required for early embryonic development. Most d-tacc mutants arrest in the first mitotic division (Gergely et al., 2000b) . This protein is also required for the formation of meiotic spindles, and a third of d-tacc spindle mutants show tripolar spindle morphology (Cullen and Ohkura, 2001) . In Caenorhabditis elegans, TAC-1 depletion leads to defects in pronuclear migration and spindle elongation in the one-cell stage embryo (Bellanger and Gonczy, 2003; Le Bot et al., 2003; Srayko et al., 2003) . Using a Xenopus egg extract system, Aurora-A has been shown to phosphorylate TACC to induce its relocalization to centrosomes, where it interacts with XMAP215 and stabilizes microtubules by opposing the destabilizing activity of mitotic centrosome-associated kinesin (MCAK) (Kinoshita et al., 2005) . In contrast to these species, the role of TACC3 in mammalian cells has not been elucidated fully. TACC3 depletion in HeLa cells was shown to induce chromosome alignment defects without affecting bipolar spindle assembly (Gergely et al., 2003) . However, longterm TACC3 depletion in the same cells influenced mitotic spindle assembly, and the cells eventually underwent apoptosis (Schneider et al., 2007) . The role of Tacc3 in spindle assembly and mitotic progression has also been shown in fibroblasts from Tacc3 conditional knockout mice (Yao et al., 2007) . In contrast to these observations, Tacc3 depletion has been shown to trigger a post-mitotic p53-p21 pathway, which resulted in a reversible cell-cycle arrest without affecting mitotic progression in different cell lines (Schneider et al., 2008; Schmidt et al., 2010) . Similar observations were made in vivo when embryonic hematopoietic cell lineages from Tacc3-knockout mice showed impaired proliferation ability and expansion, which was associated with increased p21 expression (Piekorz et al., 2002) . These observations indicate that Tacc3 has multiple roles in mammalian cells, and its depletion leads to different phenotypes in a cell context-dependent manner.
Human TACC3 was originally isolated as a cancerrelated gene that mapped to chromosome region 4p16, which is close to a translocation breakpoint found in multiple myeloma (Ma et al., 2003; Jacquemier et al., 2005; Lauffart et al., 2005; Jung et al., 2006) . Subsequent studies indicated that TACC3 was aberrantly expressed in a variety of human cancers (Ma et al., 2003; Jacquemier et al., 2005; Lauffart et al., 2005; Jung et al., 2006) . Therefore, in this study, we explored the function of Tacc3 in both autochthonous tumors and normal tissues. Using Tacc3 conditional knockout mice, we disrupted Tacc3 in the thymic lymphomas that developed in p53-deficient mice, and we found remarkable tumor regression that was accompanied by massive apoptosis. Notably, normal tissues, including the thymus, showed no overt alterations after Tacc3 depletion. in vitro analysis showed that thymic lymphoma cells showed multi-polar spindle formation in response to Tacc3 disruption. We also showed that TACC3 was required for cell proliferation in Burkitt's lymphoma and acute T-cell leukemia (T-ALL) cells. These findings indicate that Tacc3 has indispensable roles in certain tumors, making this molecule a promising target for cancer chemotherapy.
Results
Tacc3 disruption leads to the regression of thymic lymphomas in p53-deficient mice To explore the function of Tacc3 in tumor tissues, we first examined its protein expression in several mouse tumor subtypes that developed in p53-deficient mice.
Tacc3 was expressed in a variety of tumors and its expression level varied between tumor types (Supplementary Figure 1 ). Among these tumor types, the Tacc3 protein was highly expressed in thymic lymphomas, which contain a large population of proliferating (that is, Ki67-positive) and mitotic (that is, phospho-H3-positive) cells, which suggests that the Tacc3 protein expression level is, at least in part, because of the tumor cell-cycle status.
To investigate Tacc3 function in vivo, we used Tacc3 conditional knockout mice (Yao et al., 2007) . We crossed these mice with p53-deficient (Jacks et al., 1994) and R26CreERT2 mice that carry a Cre recombinase fused to the mutant estrogen receptor T2 allele targeted to the ubiquitously expressed ROSA 26 locus (Ventura et al., 2007) ; CreERT2) as control. The use of R26CreERT2 mice permitted recombination in p53-deficient tumors (Ventura et al., 2007) . We administered 4-hydroxytamoxifen (4OHT) by subcutaneous injection, which was more efficient at inducing recombination than intraperitoneal injection. These animals underwent periodic magnetic resonance imagings (MRIs) to identify new tumors, and mice carrying tumors were treated with 4OHT and re-examined to measure the tumor volume at the indicated time points.
4OHT treatment in Tacc3 S/D mouse caused the regression of autochthonous thymic lymphoma ( Figure 1a , mouse-A). The tumor volume was reduced to 96% and 26% of the original volume, over 3 and 10 days, respectively. This effect was due to Tacc3 deletion rather than 4OHT treatment because the same 4OHT treatment in Tacc3 S/W mouse caused a rapid increase in tumor volume (mouse-B, 156% and 368% over 3 and 10 days, respectively; Figure 1a ). To exclude tumor variation, the volume of a given tumor was measured in the absence of 4OHT treatment for 7 days and then in the presence of treatment for 14 days (Figure 1b 4OHT-treated mice (mice B and F) showed tumor growth to a volume of 189.3% to 607.7% of the original tumor in 7 or 10 days, respectively. These observations show that Tacc3 has a critical role in the progression and maintenance of p53-deficient thymic lymphomas, and that Tacc3 disruption results in rapid tumor (Schmidt et al., 2010) , we looked for senescence in thymic lymphomas ( Figure 2a ). As expected, owing to the p53 deficiency, p21, which was efficiently induced by TACC3 depletion in breast cancer cells (Schmidt et al., 2010) , was not detected in any of the tumors. Other markers, including p16, HP1g and H3K9me3, were expressed weakly, but no significant change was observed after Tacc3 deletion, indicating that senescence was not induced by Tacc3 depletion in lymphoma cells. However, Tacc3 disruption induced massive apoptosis (Figure 2b ). Immunofluorescence microscopy showed that 4OHT treatment led to a significant decrease in Tacc3 expression and, concomitantly, a remarkable increase in TUNEL (TdT-mediated dNTP nick-end labeling)-positive cells in Tacc3 S/D mice ( Figure 2b ). These results indicate that apoptosis, rather than senescence, is the cause of thymic lymphoma regression in response to Tacc3 disruption. We next examined the response to Tacc3 depletion in the normal thymi of p53-deficient mice ( Supplementary  Figure 3) . The normal thymus expresses high Tacc3 levels and shows active proliferation, as shown by proliferating-cell nuclear antigen (PCNA) staining. However, in contrast to thymic lymphoma and despite effective Tacc3 depletion after 4OHT administration, apoptosis was not induced (Supplementary Figures 3a  and b) . Furthermore, no indication of senescence was observed, confirming active cell proliferation (Supplementary Figure 3c ). We next examined the normal thymi of mice with wild-type p53 to determine whether the lack of apoptosis and senescence after Tacc3 depletion was because of p53 deficiency (Figure 3 ). Similar to the observations in p53-deficient mice, the normal thymi expressed high Tacc3 levels, which were depleted effectively by 4OHT administration (Figure 3a) . However, no significant increase in apoptosis was observed, and cell proliferation, as indicated by PCNA staining, was not affected (Figure 3b ), indicating that Tacc3 is dispensable in normal lymphocytes that express the p53 protein. Furthermore, p21 was not detected after Tacc3 depletion, and other senescence markers, including p16, HP1g and H3K9me3, were not induced ( Figure 3c ). These observations indicate that the lack of apoptosis in the normal thymus is not because of induction of cellular senescence. We also examined the cell population in thymi after Tacc3 depletion ( Figure 3d ). Unexpectedly, 4OHT administration significantly altered the proportion of lymphocytes. For example, in wild-type mice, the proportion of CD4/8-double-positive cells was 83.6 ± 1.1% (n ¼ 4), which was significantly higher than that in 4OHT-treated mice (63.5 ± 6.8%, n ¼ 4; P ¼ 0.0006, t-test). Consistent with this, the percentage of CD4/8-double-positive cells in 4OHT-treated Tacc3 S/W mice was 71.3±1.6% (n ¼ 3), which was similar to that in Tacc3 S/D mice (66.9±8.1%, n ¼ 3, P40.05, t-test). These results show that, in contrast to lymphoma cells, normal lymphocytes do not require Tacc3 for proliferation, differentiation or maintenance.
We next analyzed other normal tissues following 4OHT administration. Hematoxylin and eosin staining indicated that administering 4OHT to Tacc3 S/D mice did not alter the gross structure of normal tissues (Supplementary Figure 4 ). Immunofluorescence analysis showed a low level of Tacc3 expression in many adult tissues, with the exception of the spleen. The lymphocytes in this tissue expressed a high level of Tacc3, and its depletion did not induce apoptosis, which was similar to the lymphocytes observed in the thymus. Because transit-amplifying intestinal cells express high Tacc3 levels, we examined the role of Tacc3 in these cells in detail ( Figure 4 ). 4OHT administration effectively depleted Tacc3; however, apoptosis was not induced in either the small intestine or the colon (Figure 4a ). No significant change in cell proliferation was observed. Consistent with this, none of the senescence markers p21, p16, HP1g and H3K9me3 was induced ( Figure 4b) . Similarly, the matrix cells located within hair follicles expressed high Tacc3 protein levels, and Tacc3 depletion by K14-Cre recombination did not result in any overt phenotypic changes. We examined these mice for more than 2 years and did not observe any skin abnormalities, Tumor regression by TACC3 disruption R Yao et al such as alopecia or dermatitis. PCNA staining showed that cell proliferation was not affected (Figure 4c ). These results provide in vivo evidence that, in contrast to thymic lymphoma cells, Tacc3 is dispensable in normal adult tissues, including the thymus, intestine and skin. These observations are of particular interest because Tacc3 is indispensable for development, and its depletion has been shown to lead to apoptosis in several cell lineages, including sclerotomal mesenchymal cells and embryonic hematopoietic cells (Piekorz et al., 2002; Yao et al., 2007) .
Tacc3 disruption in mouse lymphoma cells induces the formation of multi-polar spindles, followed by rapid apoptosis We established four cell lines to further explore the apoptotic mechanisms in Tacc3-depleted thymic lymphomas. Of these cell lines, two each were from the p53 Tumor regression by TACC3 disruption R Yao et al early as 2 days after 4OHT treatment (Figure 5a ). The growth of these cells was severely suppressed, whereas that of the Tacc3 S/W cells was not affected by 4OHT treatment, indicating that Tacc3 S/D cell growth inhibition was because of loss of Tacc3 protein expression (Figure 5b) . Fluorescence-activated cell sorting (FACS) analysis indicated that addition of 4OHT to Tacc3 S/D cells led to significant increases in the proportion of the cell population in the sub-G 1 phase, whereas no significant change was observed in the Tacc3 S/W cells ( Figure 5c ). These observations show that Tacc3 is required for cell proliferation, and its depletion leads to apoptosis, supporting the in vivo tumor regression observed in response to Tacc3 disruption. S/D cells were treated as described in panel d, fixed and stained for Tacc3 (purple), g-tubulin (red) and a-tubulin (green). The cell nuclei were stained with DAPI (blue). Each signal is shown in the black and white panels. Bar ¼ 10 mm. (f) Cells were stained described in panel e and the percentages of cells containing normal bipolar spindles (light blue and light red) and multi-polar spindles (dark blue and dark red) were determined by counting at least 50 mitotic cells in each of three independent experiments. Tacc3-positive and Tacc3-negative cells are shown in blue and red, respectively. (g) Tacc3 S/D cells expressing H2B-GFP were left untreated (4OHT(À)) or treated with 4OHT (4OHT( þ )), and mitosis was examined by chromosomal behavior using time-lapse imaging. Time 0:00 was defined as the point of nuclear envelope breakdown. The red arrows indicate cells undergoing mitotic slippage, and the green arrow indicates cell dying during mitosis. (h) Cell fates of the indicated cells with or without 4OHT treatment were determined as described in panel g. Normal mitosis is shown in blue. Death during mitosis and mitotic slippage are indicated in green and red, respectively. The P-value (t-test) is indicated.
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Because Tacc-family proteins are involved in spindle assembly (Peset and Vernos, 2008) , we next investigated lymphoma cell mitosis in response to Tacc3 depletion to elucidate the cause of apoptosis. Consistent with previous reports (Gergely et al., 2000a; Piekorz et al., 2002; Schneider et al., 2007) , Tacc3 accumulated at the mitotic spindles and centrosome during the mitotic phase in mouse lymphoma cells (Supplementary Figure  5) . Disruption of Tacc3 by 4OHT treatment increased the mitotic index (Figure 5d ), indicating that Tacc3 has a critical role in mitosis and its depletion causes mitotic arrest in lymphoma cells, which confirms previous reports in HeLa cells (Gergely et al., 2003; Schneider et al., 2007) . To understand the mitotic defects that result from Tacc3 disruption, we examined mitotic cells by immunofluorescence microscopy and found that the chromosomes were not aligned properly at the metaphase plate (Figure 5e , 4,6-diamidino-2-phenylindole (DAPI)). Interestingly, the Tacc3-depleted lymphoma cells contained multi-polar spindles (Figures 5e and f) . Three days after 4OHT administration, Tacc3 expression was absent in 90.9% of the cells and 57.9% of these cells contained multi-polar spindles (Figure 5f ). The defects in chromosome alignment and hypo-morphic spindles have been described previously in other cell types (Gergely et al., 2003; Yao et al., 2007; Barr and Gergely, 2008) , and multi-polar spindles were observed after prolonged Tacc3 depletion by inducible RNA interference in HeLa cells (Schneider et al., 2007) . The multi-polar spindles observed in the Tacc3-depleted lymphoma cells could be because of supernumerary centrosomes. In fact, these cells were established from p53-deficient mice, in which centrosome amplification may be induced (Tarapore and Fukasawa, 2002) . However, immunofluorescence staining of the centrosome showed that these cells contained normal numbers of centrosomes (Figure 5e ). In addition, cells with multipolar spindles were observed as early as 24 h after 4OHT treatment. These results indicate that neither centrosome amplification nor failure of the previous round of cytokinesis was the cause of this defect. It is more likely that the multi-polar spindles were produced by centrosomal fragmentation or ectopic nucleation of the minus ends of the spindle microtubules. This hypothesis was supported by the observation that the mitotic spindles in these cells were hypo-morphic and the signals from the centrosomal components, including g-tubulin, at each spindle pole of the multi-polar spindles were consistently weaker than those of the bipolar spindles (Figure 5e ).
Spindle defects activate the spindle assembly checkpoint, which leads to mitotic arrest. Prolonged arrest can induce cells to die during mitosis or to exit mitosis in a phenomenon called mitotic slippage. FACS analysis indicated that Tacc3 disruption increased the apoptotic cell population, but changed the tetraploid cell population only minimally (Figure 5c ), suggesting that lymphoma cells underwent mitotic cell death. Alternatively, these cells may rapidly undergo apoptosis after mitotic slippage. We tested these possibilities in a singlecell-based assay (Figures 5g and h , and Supplementary Movies 1 and 2). We used time-lapse microscopy to examine chromosome behavior during mitosis in thymic lymphoma cells expressing histone H2B-green fluorescent protein (GFP). After nuclear envelope breakdown, Tacc3 S/W cells completed mitosis and generated daughter cells in the absence or presence of 4OHT in 53.8 ± 8.9 and 60.0±13.19 min, respectively. Although the Tacc3 S/D cells completed mitosis in 59.6 ± 15.3 min in the absence of 4OHT, the majority of Tacc3 S/D cells died following 4OHT treatment, with 17.6% dying in mitosis and 70.6% undergoing mitotic slippage followed by cell death in the subsequent interphase. Notably, the cells died rapidly after nuclear envelope breakdown (at 116.7±16.1 min for cells dying in mitosis and at 155.4 ± 39.6 min for cells dying in the following interphase), which explains the minimal changes in the G 2 /M population in the FACS analysis (Figure 5c ) and the rapid in vivo regression of thymic lymphoma tissues (Figure 1 ). These results show that the loss of Tacc3 function in lymphoma cells leads to aberrant spindle formation, resulting in mitotic arrest and rapid cell death.
Tacc3 disruption induces multi-polar spindle formation, followed by rapid apoptosis in Burkitt's lymphoma and T-ALL cells Our results showed that, in mouse thymic lymphoma cells, Tacc3 was indispensable for spindle assembly, and its depletion led to multi-polar spindle formation and mitotic arrest, followed by cell death. The aberrant spindle formation and subsequent apoptosis have been described in HeLa cells (Schneider et al., 2007) , whereas other cells showed different responses when Tacc3 was depleted (Gergely et al., 2003; Schneider et al., 2008; Fielding et al., 2010; Schmidt et al., 2010) . Therefore, we Using a tissue microarray, we first examined TACC3 expression in lymphoma cells and found that both B-cell (10/10) and T-cell (10/10) lymphomas expressed high levels of the TACC3 protein (Figure 6a) . To investigate the role of TACC3 in human lymphoma cells, we used two Burkitt's lymphoma cell lines, Daudi and Raji, and two T-ALL cell lines, Jurkat and CCRF-CEM. These four cell lines contain p53 mutations: Daudi and Jurkat contain nonsense mutations, and Raji and CCRF-CEM have missense mutations (Cheng and Haas, 1990; Farrell et al., 1991; Gaidano et al., 1991; Chow et al., Tumor regression by TACC3 disruption R Yao et al 1993; Cinti et al., 2000; Bamford et al., 2004) . The Tacc3 protein was expressed in these cells, and the T-ALL cells showed higher expression than the Burkitt's lymphoma cells. To deplete Tacc3 expression, we expressed five short-hairpin RNAs (shRNAs) using lentivirus and found that two independent shRNA constructs significantly reduced the Tacc3 protein level with varying efficiencies (Figure 6b ). Tacc3 depletion in the lymphoma cell lines significantly reduced cell viability and its efficiency varied among cell lines (Figure 6c ). Tacc3 depletion by sh1 reduced viability to 44.9±8.1% and 43.5 ± 3.3% in Daudi and Raji cells, respectively, and 25.1±4.3% in CCRF-CEM cells. Of note, despite high Tacc3 expression and its efficient depletion, Jurkat cells showed a minimal reduction in cell viability (79.5 ± 12.6%). Annexin-V staining showed that Tacc3 depletion induced apoptosis in all the cells tested ( Figure 6d ). As observed in mouse thymic lymphoma cells (Figure 5d ), human lymphoma cells showed a significantly increased mitotic index (Figure 6e ), indicating that TACC3 is indispensable for the mitotic progression of these cells. Immunofluorescence staining indicated that Tacc3 localized to the mitotic spindle and centrosomes, and its depletion led to an increase in cells containing multi-polar spindles (Figures 6f and g ). These results show that, similar to mouse thymic lymphoma cells, human lymphoma cells require Tacc3 for bipolar spindle formation and its depletion causes mitotic arrest, followed by apoptosis.
Unexpectedly, 49.7% of the Jurkat cells contained multi-polar spindles even before Tacc3 depletion, which suggests that these cells contained amplified centrosomes (Figure 6g ). This possibility was tested by immunofluorescence staining of the centrosomes (Supplementary Figure 6) . Two centrosome components, g-tubulin and pericentrin, were localized at each pole of the multi-polar spindles (Supplementary Figure 6a) . Furthermore, centrioles were detected in each pole of the multi-polar spindles, indicating that Jurkat cells contain amplified centrosomes. In cells with bipolar spindles, more than two centrin-2 signals were detected (Supplementary Figure 6b , insets in the lower panel), which suggests that Jurkat cells have mechanisms that cluster supernumerary centrosomes to form bipolar spindles, which is a mechanism that many cancer cells develop to avoid cell death from the multi-polar division (Quintyne et al., 2005; Kwon et al., 2008) . Importantly, g-tubulin, pericentrin and centrin-2 were also localized at every spindle pole in the Tacc3-depleted cells. These observations indicate that, in addition to normal bipolar spindle formation, Tacc3 has a role in the clustering of amplified centrosomes, which has been reported recently in breast and prostate cancer cells (Fielding et al., 2010) . These results may explain the minimal reduction in Jurkat cell viability in response to Tacc3 depletion (Figure 6c ).
Discussion
In this study, we showed that Tacc3 disruption led to the rapid regression of primary thymic lymphomas that developed in p53-deficient mice. in vitro analyses showed that Tacc3 depletion induced multi-polar spindles, leading to mitotic arrest and apoptosis. Recently, Tacc3 depletion has been shown to sensitize paclitaxel-induced cell death in breast cancer cells, and Tacc3 has been proposed to be a potential target to improve the chemosensitivity of tumor cells against microtubuletargeting drug (Schneider et al., 2008; Schmidt et al., 2010) . Our results indicated that, in lymphoma cells, Tacc3 depletion induced cell death by interfering with mitosis. Aberrant mitosis has been described previously in several mammalian cells, and multi-polar spindles were also observed following prolonged Tacc3 depletion in HeLa cells (Schneider et al., 2007) . Our observations indicate that Tacc3 has direct roles in the spindle assembly in lymphoma cells, and is a bona fide molecular target for cancer therapy in this tumor type. The mitotic spindle is a validated chemotherapeutic target, and our results raise the possibility that, unlike the microtubule components, Tacc3 is a potential cancer therapeutic because its disruption leads to the interference of the spindle-assembling machinery that functions in tumor cells.
From a therapeutic point of view, it is crucial to identify tumor types that are susceptible to TACC3 depletion. In this study, we showed that Tacc3 was highly expressed in mouse thymic lymphomas, and this elevated expression was associated with high mitotic activity, as shown by Ki67 and phospho-histone H3 staining (Supplementary Figure 1) . Several gene expression profile analyses have shown aberrant TACC3 expression in human cancers, including those of the breast and lung (Ma et al., 2003; Jacquemier et al., 2005; Lauffart et al., 2005; Jung et al., 2006 ). An analysis of the Oncomine database showed that the Tacc3 expression level is elevated significantly in sarcomas and several cancers, including bladder, brain and CNS, as compared with that in their corresponding normal tissues. Although the biological significance of aberrant Tacc3 expression is not known, these cancers are potential therapeutic targets for Tacc3 depletion.
In contrast to thymic lymphoma, Tacc3 depletion in the normal thymus did not produce overt abnormalities, suggesting that Tacc3 has tumor-specific roles. Hence, the question remains as to why lymphoma cells are more susceptible to Tacc3 depletion than are normal lymphocytes. Hyper-amplification of the centrosome has been observed in many tumor cells (D'Assoro et al., 2002) , and cancer cells acquire mechanisms that cluster supernumerary centrosomes to form bipolar spindles (D' Assoro et al., 2002; Quintyne et al., 2005) . The involvement of TACC3 in this process has been reported recently for breast and prostate cancer cells (Fielding et al., 2010) . In this study, we showed that TACC3 has a role in clustering the supernumerary centrosomes in Jurkat cells (Supplementary Figure 7) . However, we showed that TACC3 also has a pivotal role in the spindle assembly of tumor cells with a normal number of centrosomes. These observations showed that, in addition to the supernumerary centrosome, other alterations of the spindle assembly mechanism during tumorigenesis makes tumor cells more susceptible to Tacc3 depletion. Alterations in the cancer cell gene expression profile may provide the key to the tumor-specific spindle assembly machinery. Some obvious candidate genes include Tacc1 and Tacc2, although their functional redundancies have not been demonstrated (Schuendeln et al., 2004) . The mitotic proteins involved in centrosome function and microtubule stability are also potential candidates. Aurora-A phosphorylates Tacc3 to regulate its centrosomal localization (Kinoshita et al., 2005) . In Drosophila, D-TACC stabilizes the association of mini-spindles with the minus ends of the microtubules at the centrosome, which permits the stabilization and growth of the microtubules (Gergely et al., 2000b; Cullen and Ohkura, 2001; Lee et al., 2001) . Aurora-A and the human homolog of mini-spindles, TOGp, are also expressed aberrantly in several human cancers (Charrasse et al., 1995) , which makes it tempting to speculate that the aberrant expression of these proteins results in a requirement for TACC3 in tumor cells. Elucidating the molecular mitotic mechanisms that determine TACC3 dependency is particularly important for identifying potential chemotherapeutic targets.
In addition to aberrant spindle assembly, the cellular responses after spindle assembly checkpoint activation are critical determinants of the efficacy of non-microtubule mitotic protein-targeted cancer chemotherapies. The fate of a cell following mitotic arrest has been proposed to be dictated by two competing networks: the cell death pathway and the cellular mechanisms that prevent cyclin-B1 degradation (Gascoigne and Taylor, 2008) . The observation that lymphoma cells undergo rapid apoptosis after nuclear envelope breakdown suggests that these cells have a strong intrinsic death response, which may explain why a significant number of cells undergo apoptosis following mitotic slippage. These cells probably commit to the apoptotic pathway during mitotic arrest and die shortly after cell-cycle progression. Although the apoptosis that follows mitotic arrest is caspase-dependent, the mechanism by which cells undergo apoptosis during arrest is largely unknown (Janssen et al., 2007; Gascoigne and Taylor, 2008) . Elucidation of these mechanisms will facilitate understanding of the molecular basis of the antitumor activity of Tacc3 depletion.
Our results indicate that Tacc3 is indispensable for mitosis in normal lymphocytes, intestinal transit-amplifying cells and follicular matrix cells; however, its role in other normal cell lineages remains unclear. In fact, we and others have shown previously that Tacc3 is indispensable for embryonic development (Piekorz et al., 2002; Yao et al., 2007) . It should be noted that the results of the present study do not exclude the possibility that Tacc3 is required for some adult tissues. For example, it may be required for tissue homeostasis, such as in wound healing. The analysis of Tacc3 function in adult tissues is of particular interest, and a greater understanding of this function may help in avoiding the side effects of Tacc3-targeted cancer chemotherapy.
The determination of Tacc3 function in a genetically modified mouse model of cancer is important for several reasons. In contrast to in vitro cell culture systems or xenograft models, autochthonous tumors are more similar to human cancers with regard to cellular heterogeneity and the tumor microenvironment. By using the R26CreERT2 allele, which ubiquitously expresses Cre recombinase, we were able to assess the effects of Tacc3 disruption in normal tissues. Finally, unlike small compounds that inhibit structurally related proteins, genetic disruption in conditional knockout mice disturbs the function of a specific molecule, without affecting other family members. Because several other potential chemotherapeutic targets, including Aurora kinases and Polo-like kinases, have structurally related family members, this approach is valuable for investigating the function of individual molecules and for developing selective chemotherapeutic inhibitors with minimal side effects. Our observations that Tacc3 disruption led to in vivo tumor regression strongly indicate that targeting Tacc3 is a promising treatment for human cancers. A specific Tacc3 inhibitor may be able to exert sufficient antitumor activity with minimal side effects.
Materials and methods

Mice
All animal studies and procedures were approved by the JFCR Cancer Institute Animal Committee, and the Animal Welfare and Use Committee of the National Institute of Radiological Sciences (Japan). Conditional Tacc3-knockout mice, which were generated as described by Yao et al. (2007) , were crossed with p53-knockout and R26CreERT2 mice to obtain p53 À/À ; Tacc3 S/W ; CreERT2 and p53
; Tacc3 S/D ; CreERT2 mice, which were in a mixed 129Sv/J and C57BL/6 background. 4OHT (100 ml of a 10 mg/ml solution in corn oil; obtained from Sigma (St Louis, MO, USA)) was administered by subcutaneous injection.
MRI measurements
Proton MRI was performed using a 7.0-T, 40-cm bore magnet (Kobelco Inc., Kobe, Japan and Jastec Inc., Kobe, Japan) interfaced to a Bruker Avance-I console (Bruker BioSpin, Ettlingen, Germany). A 25-mm-diameter birdcage coil (Rapid Biomedical, Rimpar, Germany) was used for whole-body coverage, and T 1 -weighted, multi-slice, two-dimensional spinecho images were obtained. MRI acquisitions were performed using the following parameters: repetition time/echo time ¼ 400/9.5 ms; matrix size ¼ 256 Â 256; field of view-¼ 32 Â 32 mm 2 (trans-axial) or 80 Â 32 mm 2 (horizontal); slice thickness ¼ 1.5 mm (trans-axial) or 1 mm (horizontal); slice gap ¼ 0 mm; and number of averages ¼ 4. Four sets of T 1 -weighted MRI images, which consisted of one horizontal and three trans-axial image sets, were acquired for the whole-body coverage. The nominal voxel resolution was 125 Â 125 Â 1500 mm 3 for the trans-axial orientation and 312 Â 125 Â 1000 mm 3 for the horizontal orientation. The total acquisition time to obtain the four sets of T 1 -weighted MRI images was 27 min. Image reconstructions and analyses were performed using the ParaVision (Bruker BioSpin) and the Image-J software (ver. ; Tacc3 S/D ; 4OHT( þ ) and the control mice groups (Prism ver. 5; GraphPad Software, La Jolla, CA, USA). Statistical significance was set at Po0.05.
Antibodies and TUNEL assay An antibody against mouse Tacc3 was generated as described previously by Yao et al. (2007) . Antibodies against human TACC3 were generated by immunizing rabbits with a peptide corresponding to amino acids 213-224 of human TACC3. The immune serum was purified using a peptide-coupled immunoaffinity column. Anti-PCNA (CBL407) and anti-GADPH (FL-335) antibodies were purchased from Chemicon (Temecula, CA, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA), respectively. Antibodies against a-tubulin (DM1A) and g-tubulin (GTU-88, AK-15 and DQ-19) were purchased from Sigma. For triple-label immunofluorescence microscopy, samples were stained with fluorescein isothiocyanate-conjugated anti-a-tubulin (Sigma), Cy3-conjugated gtubulin (Sigma) and anti-human TACC3 antibody labeled with Alexa Fluor-647 (Invitrogen, Camarillo, CA, USA). Antiphospho-histone H3 (Ser10) and anti-MPM-2 antibodies were purchased respectively, from Cell Signaling (Danvers, MA, USA) and Novus (Littleton, CO, USA). Anti-centrin-2 (N-17) and anti-pericentrin (PRB-432C) antibodies were purchased from Santa Cruz Biotechnology and Covance (Emeryville, CA, USA), respectively. TUNEL assays were performed using the ApoTag PLUS Fluorescein In situ Apoptosis Detection kit (Chemicon), according to the manufacturer's instructions.
Histology and immunohistochemistry
Tissues were fixed in 10% buffered formalin (Wako, Osaka, Japan) and were paraffin-embedded, and 4 or 6-mm sections were prepared. A formalin-fixed human lymphoma tissue array (NHL401) was purchased from BioMax (Rockville, MD, USA). Sections were deparaffinized and stained with hematoxylin and eosin. To detect Tacc3, Ki67 and phospho-H3, antigens were retrieved by boiling in 0.1 M citrate buffer (pH 6.0) using a microwave oven and colorimetric detection was performed using the Histofine staining kit (Nichirei, Tokyo, Japan) and a peroxidase substrate kit (Vector, Burlingame, CA, USA). Immunohistochemistry to measure cellular senescence was performed as described previously by Shamma et al. (2009) .
Mouse tumor cells
To generate cell lines from mouse thymic lymphomas, tumors were minced with a razor blade, filtered through a 70-mm filter and plated in GIT medium (Nihon pharmaceutical, Tokyo, Japan). To determine the DNA content, the cells were fixed in ice-cold methanol, stained with propidium iodide and analyzed by flow cytometry using a FACSCalibur cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). Stable clones constitutively expressing H2B-GFP were obtained by lentiviral transduction with a pLenti4/V5-DEST vector (Invitrogen). The infected cells were selected in zeocin and purified by FACS sorting using a FACSAria cell sorter (Becton Dickinson). 4OHT was diluted to 25 mM in ethanol and used at a final concentration of 1 mM.
TACC3 knockdown and cell viability assays of human lymphoma cells Human lymphoma cell lines were cultured in RPMI1640 medium (Invitrogen) supplemented with 10% bovine calf serum. The cells were transduced with a pLKP.1puro lentiviral shRNA vector obtained from the TRC shRNA Library (TRCN0000062023-27; Open Biosystems, Huntsville, AL, USA). Two clones, TRCN0000062026 (sh1) and TRCN0000062027 (sh2), were chosen because of their significant depletion. Lentiviral particles were produced by co-transfection of 293T cells with pLKO.1 constructs, and the pMD2.G and psPAX2 plasmids using Lipofectamine 2000 (Invitrogen). Supernatants were collected 48 and 72 h after transfection. The cells were incubated with the lentiviral supernatants for 24 h in the presence of 6 mg/ml polybrene (Sigma), and infected cells were selected in 2 mg/ml (Daudi, Jurkat and CCRF-CEM) or 4 mg/ml (Raji) puromycin. Immunoblot analysis was performed 48 h after infection. The number of viable cells was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (Roche, Basel, Switzerland) on four consecutive days. Annexin-V staining was performed 72 h after infection using an Annexin-V-FLUOS staining kit (Roche) according to the manufacturer's instructions.
Immunoblotting
Total cell lysates were prepared in 1% NP-40 buffer (1% NP-40, 50 mM Tris-HCl (pH 8.0), 150 mM NaCl and 10% glycerol) containing protease and phosphatase inhibitors (Roche). Equal amounts of proteins were separated by sodium dodecyl sulfate-PAGE and transferred to nitrocellulose membranes. The blots were incubated with primary antibodies, followed by incubation with a peroxidaseconjugated secondary antibody, and visualized using an ECL detection system (GE Healthcare, Buckinghamshire, UK). For quantitation, the blots were scanned and the total pixel intensity was counted using the Image-J 1.42a software.
Immunofluorescence Cells were fixed in 3.7% parafomaldehyde and permeabilized in 0.2% Triton X-100 in phosphate-buffered saline or fixed in methanol/acetone (1:1). After primary antibody incubation, the cells were washed with phosphate-buffered saline and incubated with fluorescein isothiocyanate-conjugated anti-mouse IgG and/or Cy3-conjugated anti-rabbit IgG (Chemicon). DNA was visualized using DAPI. Imaging was performed using a Leica DM6000B microscope equipped with a Â 100/1.40-0.70 Plan Apo objective lens and Zprojections.
Time-lapse imaging
Mouse lymphoma cells expressing histone H2B-GFP were plated on 60-mm glass bottom plates (IWAKI, Tokyo, Japan). Fluorescence images were acquired every 10 min using a Leica AF6000 microscope with a Â 40/1.40-0.70 Plan Apo objective lens. Cell fates were determined manually using the Image-J 1.42a software.
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